Follow
chiara orlandi
chiara orlandi
Adjunct Faculty at IHV, University of Maryland
Verified email at ihv.umaryland.edu - Homepage
Title
Cited by
Cited by
Year
Effects and interactions in an environmentally relevant mixture of pharmaceuticals
F Pomati, C Orlandi, M Clerici, F Luciani, E Zuccato
Toxicological Sciences 102 (1), 129-137, 2008
2492008
Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4
M Molteni, D Marabella, C Orlandi, C Rossetti
Cancer letters 235 (1), 75-83, 2006
1272006
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein
P Gilchuk, N Kuzmina, PA Ilinykh, K Huang, BM Gunn, A Bryan, ...
Immunity 49 (2), 363-374. e10, 2018
592018
Cocrystal structures of antibody N60-i3 and antibody JR4 in complex with gp120 define more cluster A epitopes involved in effective antibody-dependent effector function against …
N Gohain, WD Tolbert, P Acharya, L Yu, T Liu, P Zhao, C Orlandi, ...
Journal of virology 89 (17), 8840-8854, 2015
512015
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Immunity, 2020
492020
Paring down HIV Env: design and crystal structure of a stabilized inner domain of HIV-1 gp120 displaying a major ADCC target of the A32 region
WD Tolbert, N Gohain, M Veillette, JP Chapleau, C Orlandi, ML Visciano, ...
Structure 24 (5), 697-709, 2016
482016
A single dose of modified vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge
A Domi, F Feldmann, R Basu, N McCurley, K Shifflett, J Emanuel, ...
Scientific Reports 8 (1), 1-9, 2018
422018
A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies
C Orlandi, R Flinko, GK Lewis
Journal of Immunological Methods 433, 51-58, 2016
412016
Targeting the late stage of HIV-1 entry for antibody-dependent cellular cytotoxicity: structural basis for Env epitopes in the C11 region
WD Tolbert, N Gohain, N Alsahafi, V Van, C Orlandi, S Ding, L Martin, ...
Structure 25 (11), 1719-1731. e4, 2017
332017
Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240
N Gohain, WD Tolbert, C Orlandi, J Richard, S Ding, X Chen, DA Bonsor, ...
Scientific reports 6 (1), 1-15, 2016
272016
Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell‐mediated cytotoxicity assay
J Pollara, C Orlandi, C Beck, RW Edwards, Y Hu, S Liu, S Wang, RA Koup, ...
Cytometry Part A 93 (4), 436-447, 2018
152018
Antigen-induced allosteric changes in a human IgG1 Fc increase low-affinity Fcγ receptor binding
C Orlandi, D Deredge, K Ray, N Gohain, W Tolbert, AL DeVico, ...
Structure 28 (5), 516-527. e5, 2020
132020
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
C Orlandi, G Forlani, G Tosi, RS Accolla
Journal of Translational Medicine 9 (1), 1-9, 2011
122011
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
C Orlandi, G Forlani, G Tosi, RS Accolla
Journal of Translational Medicine 9 (1), 1-9, 2011
122011
Induction of Fc-Mediated Effector Functions Against a Stabilized Inner Domain of HIV-1 gp120 Designed to Selectively Harbor the A32 Epitope Region
ML Visciano, N Gohain, R Sherburn, C Orlandi, R Flinko, A Dashti, ...
Frontiers in immunology 10, 2019
62019
A MUC16 IgG binding activity selects for a restricted subset of IgG enriched for certain simian immunodeficiency virus epitope specificities
JR Schneider, X Shen, C Orlandi, T Nyanhete, S Sawant, AM Carias, ...
Journal of virology 94 (5), e01246-19, 2020
22020
Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure
K Ray, M Mengistu, C Orlandi, M Pazgier, GK Lewis, AL DeVico
Frontiers in Immunology, 2019
22019
Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
AL Schmaljohn, C Orlandi, GK Lewis
Frontiers in Immunology 10, 2019
12019
AIDS Vaccine 2013October 7–10, 2013Barcelona, Spain
T Hertz
AIDS Research and Human Retroviruses 29 (11), A-1, 2013
12013
Trogocytosis of viral immune complexes in the context of HIV-1 infection
C Orlandi, R Flinko, K Ray, Y Hu, J Mamede, D Maric, T Hope, G Lewis
JAIDS Journal of Acquired Immune Deficiency Syndromes 81, 78, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20